Application

17909350 · IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12

Filed 2022-09-02 · Abandoned The official file ↗ · Art unit 1629 · Examiner Alexander Keith Showalter Typical · CPC C07D 487/04 · Deutsches Krebsforschungszentrum · MORRISON & FOERSTER LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

32.9 mo

to disposition 41.8 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.